Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Chronic Heart Failure

Free Subscription Articles published in Circ Res Retrieve available abstracts of 105 articles: HTML format

Single Articles

April 2024
1. QASIM H, Rajaei M, Xu Y, Reyes-Alcaraz A, et al
   AKAP12 Upregulation Associates With PDE8A to Accelerate Cardiac Dysfunction.
   Circ Res. 2024;134:1006-1022.
   PubMed     Abstract available
   
   
   March 2024
2. ECKLE T, Bertazzo J, Khatua TN, Fatemi Tabatabaei SR, et al
   Circadian Influences on Myocardial Ischemia-Reperfusion Injury and Heart Failure.
   Circ Res. 2024;134:675-694.
   PubMed     Abstract available
   
   
   
3. CURAJ A, Vanholder R, Loscalzo J, Quach K, et al
   Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways.
   Circ Res. 2024;134:592-613.
   PubMed     Abstract available
   
   
   February 2024
4. KAMRADT ML, Makarewich CA
   CHKB-DT: A Long Noncoding RNA Critical for Cardiovascular Health.
   Circ Res. 2024;134:442-444.
   PubMed    
   
   
   
5. VACCA A, Schiattarella GG
   From Gut to Heart: Role of Indole-3-Propionic Acid in HFpEF.
   Circ Res. 2024;134:390-392.
   PubMed    
   
   
   January 2024
6. WANG YC, Koay YC, Pan C, Zhou Z, et al
   Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction.
   Circ Res. 2024 Jan 24. doi: 10.1161/CIRCRESAHA.123.322381.
   PubMed     Abstract available
   
   
   December 2023
7. STEGE NM, Eijgenraam TR, Oliveira Nunes Teixeira V, Feringa AM, et al
   DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters.
   Circ Res. 2023;133:1006-1021.
   PubMed     Abstract available
   
   
   November 2023
8. DAI Z, Thorp EB
   New Way to Study Pulmonary Hypertension in HFpEF.
   Circ Res. 2023;133:899-901.
   PubMed    
   
   
   
9. AGRAWAL V, Kropski JA, Gokey JJ, Kobeck E, et al
   Myeloid Cell Derived IL1beta Contributes to Pulmonary Hypertension in HFpEF.
   Circ Res. 2023;133:885-898.
   PubMed     Abstract available
   
   
   
10. KWAN Z, Paulose Nadappuram B, Leung MM, Mohagaonkar S, et al
    Microtubule-Mediated Regulation of beta(2)AR Translation and Function in Failing Hearts.
    Circ Res. 2023;133:944-958.
    PubMed     Abstract available
    
    
    October 2023
11. LIU D, Wang M, Murthy V, McNamara DM, et al
    Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis.
    Circ Res. 2023;133:810-825.
    PubMed     Abstract available
    
    
    September 2023
12. SERIO S, Pagiatakis C, Musolino E, Felicetta A, et al
    Cardiac Aging Is Promoted by Pseudohypoxia Increasing p300-Induced Glycolysis.
    Circ Res. 2023;133:687-703.
    PubMed     Abstract available
    
    
    July 2023
13. 
    Correction to: SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.
    Circ Res. 2023;133:e48.
    PubMed    
    
    
    
14. TANG X, Zhao S, Liu J, Liu X, et al
    Mitochondrial GSNOR Alleviates Cardiac Dysfunction via ANT1 Denitrosylation.
    Circ Res. 2023;133:220-236.
    PubMed     Abstract available
    
    
    
15. DAI Y, Ignatyeva N, Xu H, Wali R, et al
    An Alternative Mechanism of Subcellular Iron Uptake Deficiency in Cardiomyocytes.
    Circ Res. 2023;133:e19-e46.
    PubMed     Abstract available
    
    
    June 2023
16. FATKIN D, Ohanian M, Brown KJ
    A Novel Role for FKBP5 in Atrial Cardiomyopathy.
    Circ Res. 2023;133:45-47.
    PubMed    
    
    
    
17. SANCHEZ-ALONSO JL, Fedele L, Copier JS, Lucarelli C, et al
    Functional LTCC-beta(2)AR Complex Needs Caveolin-3 and Is Disrupted in Heart Failure.
    Circ Res. 2023 Jun 14. doi: 10.1161/CIRCRESAHA.123.322508.
    PubMed     Abstract available
    
    
    May 2023
18. NAYAKANTI SR, Friedrich A, Sarode P, Jafari L, et al
    Targeting Wnt-ss-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling.
    Circ Res. 2023;132:1468-1485.
    PubMed     Abstract available
    
    
    
19. BOULOS PK, Freeman SV, Henry TD, Mahmud E, et al
    Interaction of COVID-19 With Common Cardiovascular Disorders.
    Circ Res. 2023;132:1259-1271.
    PubMed     Abstract available
    
    
    April 2023
20. NGUYEN TD, Schulze PC
    Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy.
    Circ Res. 2023;132:1034-1049.
    PubMed     Abstract available
    
    
    
21. WU Z, Lohmoller J, Kuhl C, Wehrle K, et al
    Use of Computation Ecosystems to Analyze the Kidney-Heart Crosstalk.
    Circ Res. 2023;132:1084-1100.
    PubMed     Abstract available
    
    
    March 2023
22. MATSUURA TR, Puchalska P, Crawford PA, Kelly DP, et al
    Ketones and the Heart: Metabolic Principles and Therapeutic Implications.
    Circ Res. 2023;132:882-898.
    PubMed     Abstract available
    
    
    
23. YE S, Huang H, Han X, Luo W, et al
    Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling.
    Circ Res. 2023;132:707-722.
    PubMed     Abstract available
    
    
    
24. CANNAVO A, Jun S, Rengo G, Marzano F, et al
    beta3AR-Dependent BDNF (Brain-Derived Neurotrophic Factor) Generation Limits Chronic Postischemic Heart Failure.
    Circ Res. 2023 Mar 8. doi: 10.1161/CIRCRESAHA.122.321583.
    PubMed     Abstract available
    
    
    
25. HUGHES A, Shandhi MMH, Master H, Dunn J, et al
    Wearable Devices in Cardiovascular Medicine.
    Circ Res. 2023;132:652-670.
    PubMed     Abstract available
    
    
    February 2023
26. YE B, Zhou H, Chen Y, Luo W, et al
    USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes.
    Circ Res. 2023;132:465-480.
    PubMed     Abstract available
    
    
    
27. SAWICKI KT, De Jesus A, Ardehali H
    Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets.
    Circ Res. 2023;132:379-396.
    PubMed     Abstract available
    
    
    
28. PI H, Xia L, Ralph DD, Rayner SG, et al
    Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes.
    Circ Res. 2023;132:254-266.
    PubMed     Abstract available
    
    
    January 2023
29. EL JAMAL N, Lordan R, Teegarden SL, Grosser T, et al
    The Circadian Biology of Heart Failure.
    Circ Res. 2023;132:223-237.
    PubMed     Abstract available
    
    
    
30. RUBINO M, Travers JG, Headrick AL, Enyart BT, et al
    Inhibition of Eicosanoid Degradation Mitigates Fibrosis of the Heart.
    Circ Res. 2023;132:10-29.
    PubMed     Abstract available
    
    
    December 2022
31. LI Z, Xia H, Sharp TE 3rd, LaPenna KB, et al
    Hydrogen Sulfide Modulates Endothelial-Mesenchymal Transition in Heart Failure.
    Circ Res. 2022 Dec 28. doi: 10.1161/CIRCRESAHA.122.321326.
    PubMed     Abstract available
    
    
    
32. DENG B, Zhang Y, Zhu C, Wang Y, et al
    Divergent Actions of Myofibroblast and Myocyte beta(2)-Adrenoceptor in Heart Failure and Fibrotic Remodeling.
    Circ Res. 2022 Dec 2. doi: 10.1161/CIRCRESAHA.122.321816.
    PubMed    
    
    
    October 2022
33. WU X, Liu H, Brooks A, Xu S, et al
    SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.
    Circ Res. 2022 Oct 24. doi: 10.1161/CIRCRESAHA.121.318988.
    PubMed     Abstract available
    
    
    September 2022
34. 
    Correction to: Mitochondrial H2S Regulates BCAA Catabolism in Heart Failure.
    Circ Res. 2022;131:e101.
    PubMed    
    
    
    
35. ZHANG J, Gutierrez-Lara EJ, Liang Y, Sheikh F, et al
    Functions Beyond the Editor's I in Regulating Cardiac Innate Immunity and Heart Failure.
    Circ Res. 2022;131:598-600.
    PubMed    
    
    
    
36. UMBARKAR P, Tousif S, Singh AP, Anderson JC, et al
    Fibroblast GSK-3alpha Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.
    Circ Res. 2022;131:620-636.
    PubMed     Abstract available
    
    
    
37. GARCIA-GONZALEZ C, Dieterich C, Maroli G, Wiesnet M, et al
    ADAR1 Prevents Autoinflammatory Processes in the Heart Mediated by IRF7.
    Circ Res. 2022;131:580-597.
    PubMed     Abstract available
    
    
    
38. TIAN C, Gao L, Rudebush TL, Yu L, et al
    Extracellular Vesicles Regulate Sympatho-Excitation by Nrf2 in Heart Failure.
    Circ Res. 2022 Sep 13:101161CIRCRESAHA122320916.
    PubMed     Abstract available
    
    
    August 2022
39. 
    Correction to: Heart Failure with Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models.
    Circ Res. 2022;131:e100.
    PubMed    
    
    
    July 2022
40. DOIRON JE, Lefer DJ
    Leveraging Adipocyte-Cardiomyocyte Signaling to Treat Ischemic Heart Failure.
    Circ Res. 2022;131:165-167.
    PubMed    
    
    
    June 2022
41. WANG X, Zhang G, Dasgupta S, Niewold EL, et al
    ATF4 Protects the Heart From Failure by Antagonizing Oxidative Stress.
    Circ Res. 2022;131:91-105.
    PubMed     Abstract available
    
    
    
42. LI Z, Xia H, Sharp TE 3rd, LaPenna KB, et al
    Mitochondrial H2S Regulates BCAA Catabolism in Heart Failure.
    Circ Res. 2022 Jun 14:101161CIRCRESAHA121319817.
    PubMed     Abstract available
    
    
    
43. PILZ PM, Ward JE, Chang WT, Kiss A, et al
    Large and Small Animal Models of Heart Failure With Reduced Ejection Fraction.
    Circ Res. 2022;130:1888-1905.
    PubMed     Abstract available
    
    
    
44. ROH J, Hill JA, Singh A, Valero-Munoz M, et al
    Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models.
    Circ Res. 2022;130:1906-1925.
    PubMed     Abstract available
    
    
    
45. BUGGER H, Byrne NJ, Abel ED
    Animal Models of Dysregulated Cardiac Metabolism.
    Circ Res. 2022;130:1965-1993.
    PubMed     Abstract available
    
    
    May 2022
46. MICHEL T, Nougue H, Cartailler J, Lefevre G, et al
    proANP Metabolism Provides New Insights Into Sacubitril/Valsartan Mode of Action.
    Circ Res. 2022;130:e44-e57.
    PubMed     Abstract available
    
    
    
47. ZHU D, Zhang Z, Zhao J, Liu D, et al
    Targeting Adiponectin Receptor 1 Phosphorylation Against Ischemic Heart Failure.
    Circ Res. 2022 May 25:101161CIRCRESAHA121319976.
    PubMed     Abstract available
    
    
    
48. PATEL KP, Katsurada K, Zheng H
    Cardiorenal Syndrome: The Role of Neural Connections Between the Heart and the Kidneys.
    Circ Res. 2022;130:1601-1617.
    PubMed     Abstract available
    
    
    
49. LIU J, Li W, Deng KQ, Tian S, et al
    The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy.
    Circ Res. 2022;130:1586-1600.
    PubMed     Abstract available
    
    
    
50. TOMA A, Dos Santos C, Burzynska B, Gora M, et al
    Diversity in the Expressed Genomic Host Response to Myocardial Infarction.
    Circ Res. 2022 May 9:101161CIRCRESAHA121318391.
    PubMed    
    
    
    April 2022
51. 
    Correction to: Heart Failure Subtypes and Cardiomyopathies in Women.
    Circ Res. 2022;130:e25.
    PubMed    
    
    
    
52. BRITTAIN EL, Hemnes AR
    Introduction to Review Series on Pulmonary Vascular Disease and Right Ventricular Heart Failure.
    Circ Res. 2022;130:1362-1364.
    PubMed    
    
    
    
53. HUSTON JH, Shah SJ
    Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
    Circ Res. 2022;130:1382-1403.
    PubMed     Abstract available
    
    
    
54. ALENEZI F, Covington TA, Mukherjee M, Mathai SC, et al
    Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.
    Circ Res. 2022;130:1445-1465.
    PubMed     Abstract available
    
    
    
55. BOUCHERAT O, Agrawal V, Lawrie A, Bonnet S, et al
    The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure.
    Circ Res. 2022;130:1466-1486.
    PubMed     Abstract available
    
    
    
56. 
    Correction to: The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.
    Circ Res. 2022;130:e23.
    PubMed    
    
    
    
57. MESUBI OO, Anderson ME
    Heart Failure and Atrial Fibrillation-Chicken or Egg?
    Circ Res. 2022;130:1011-1013.
    PubMed    
    
    
    March 2022
58. WANG J, Shi Q, Wang Y, Dawson LW, et al
    Gene Therapy With the N-Terminus of Junctophilin-2 Improves Heart Failure in Mice.
    Circ Res. 2022 Mar 23:CIRCRESAHA121320680. doi: 10.1161/CIRCRESAHA.121.320680.
    PubMed     Abstract available
    
    
    
59. 
    Correction to: Heart Failure Subtypes and Cardiomyopathies in Women.
    Circ Res. 2022;130:e21.
    PubMed    
    
    
    
60. STACHOWSKI-DOLL MJ, Papadaki M, Martin TG, Ma W, et al
    GSK-3beta Localizes to the Cardiac Z-Disc to Maintain Length Dependent Activation.
    Circ Res. 2022;130:871-886.
    PubMed     Abstract available
    
    
    
61. YAO Y, Li F, Zhang M, Jin L, et al
    Targeting CaMKII-delta9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation.
    Circ Res. 2022;130:887-903.
    PubMed     Abstract available
    
    
    
62. MA K, Yang J, Shao Y, Li P, et al
    Therapeutic and Prognostic Significance of Arachidonic Acid in Heart Failure.
    Circ Res. 2022 Mar 8:CIRCRESAHA121320548. doi: 10.1161/CIRCRESAHA.121.320548.
    PubMed     Abstract available
    
    
    February 2022
63. DEFILIPPIS EM, Beale A, Martin T, Agarwal A, et al
    Heart Failure Subtypes and Cardiomyopathies in Women.
    Circ Res. 2022;130:436-454.
    PubMed     Abstract available
    
    
    
64. KECELI G, Gupta A, Sourdon J, Gabr R, et al
    Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure.
    Circ Res. 2022 Feb 3:CIRCRESAHA121319648. doi: 10.1161/CIRCRESAHA.121.319648.
    PubMed     Abstract available
    
    
    January 2022
65. SOSSALLA S, Bers DM
    Neuron-Restrictive Silencer Factor Limits Myocyte GalphaO Expression and Is Protective in Heart Failure Progression.
    Circ Res. 2022;130:249-251.
    PubMed    
    
    
    
66. SHEA S, Blaha MJ
    Long-Term Risk Prediction for Heart Failure, Disparities, and Early Prevention.
    Circ Res. 2022;130:210-212.
    PubMed    
    
    
    
67. INAZUMI H, Kuwahara K, Nakagawa Y, Kuwabara Y, et al
    NRSF-GNAO1 Pathway Contributes to the Regulation of Cardiac Ca(2+) Homeostasis.
    Circ Res. 2022;130:234-248.
    PubMed     Abstract available
    
    
    December 2021
68. KHAN SS, Ning H, Allen NB, Carnethon M, et al
    Development and Validation of A Long-Term Incident Heart Failure Risk Model.
    Circ Res. 2021 Dec 10. doi: 10.1161/CIRCRESAHA.121.319595.
    PubMed     Abstract available
    
    
    October 2021
69. 
    Correction to: The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.
    Circ Res. 2021;129:e201.
    PubMed    
    
    
    
70. SOETKAMP D, Gallet R, Parker SJ, Holewinski R, et al
    Myofilament Phosphorylation in Stem Cell Treated Diastolic Heart Failure.
    Circ Res. 2021 Oct 13. doi: 10.1161/CIRCRESAHA.119.316311.
    PubMed     Abstract available
    
    
    September 2021
71. WANG Y, Zhao M, Shi Q, Xu B, et al
    Monoamine Oxidases Desensitize Intracellular beta1AR Signaling in Heart Failure.
    Circ Res. 2021 Sep 17. doi: 10.1161/CIRCRESAHA.121.319546.
    PubMed    
    
    
    August 2021
72. RONG J, Tao X, Lin Y, Zheng H, et al
    Loss of Hepatic Angiotensinogen Attenuates Sepsis-Induced Myocardial Dysfunction.
    Circ Res. 2021;129:547-564.
    PubMed     Abstract available
    
    
    July 2021
73. YURA Y, Miura-Yura E, Katanasaka Y, Min KD, et al
    The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.
    Circ Res. 2021 Jul 28. doi: 10.1161/CIRCRESAHA.121.319314.
    PubMed     Abstract available
    
    
    
74. PADULA SL, Yutzey KE
    Epigenetic Regulation of Heart Failure: Cell Type Matters.
    Circ Res. 2021;129:414-416.
    PubMed    
    
    
    June 2021
75. HUO JL, Jiao L, An Q, Chen X, et al
    Myofibroblast Deficiency of LSD1 Alleviates TAC-Induced Heart Failure.
    Circ Res. 2021 Jun 3. doi: 10.1161/CIRCRESAHA.120.318149.
    PubMed     Abstract available
    
    
    
76. GLASENAPP A, Derlin K, Gutberlet M, Hess A, et al
    Molecular Imaging of Inflammation and Fibrosis in Pressure Overload Heart Failure.
    Circ Res. 2021 Jun 2. doi: 10.1161/CIRCRESAHA.120.318539.
    PubMed     Abstract available
    
    
    May 2021
77. AKAR FG, Young LH
    NAD Repletion Therapy: A Silver Bullet for HFpEF?
    Circ Res. 2021;128:1642-1645.
    PubMed    
    
    
    
78. RURIK JG, Aghajanian H, Epstein JA
    Immune Cells and Immunotherapy for Cardiac Injury and Repair.
    Circ Res. 2021;128:1766-1779.
    PubMed     Abstract available
    
    
    
79. BURKE RM, Dirkx RA Jr, Quijada P, Lighthouse JK, et al
    Prevention of Fibrosis and Pathological Cardiac Remodeling by Salinomycin.
    Circ Res. 2021;128:1663-1678.
    PubMed     Abstract available
    
    
    
80. FAN J, Li H, Xie R, Zhang X, et al
    LncRNA ZNF593-AS Alleviates Contractile Dysfunction in Dilated Cardiomyopathy.
    Circ Res. 2021;128:1708-1723.
    PubMed     Abstract available
    
    
    
81. ROGER VL
    Epidemiology of Heart Failure: A Contemporary Perspective.
    Circ Res. 2021;128:1421-1434.
    PubMed     Abstract available
    
    
    
82. NJOROGE JN, Teerlink JR
    Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure.
    Circ Res. 2021;128:1468-1486.
    PubMed     Abstract available
    
    
    
83. LOPASCHUK GD, Karwi QG, Tian R, Wende AR, et al
    Cardiac Energy Metabolism in Heart Failure.
    Circ Res. 2021;128:1487-1513.
    PubMed     Abstract available
    
    
    
84. HAHN VS, Zhang KW, Sun L, Narayan V, et al
    Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection.
    Circ Res. 2021;128:1576-1593.
    PubMed     Abstract available
    
    
    
85. MANN DL, Felker GM
    Mechanisms and Models in Heart Failure: A Translational Approach.
    Circ Res. 2021;128:1435-1450.
    PubMed     Abstract available
    
    
    
86. PAULUS WJ, Zile MR
    From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.
    Circ Res. 2021;128:1451-1467.
    PubMed     Abstract available
    
    
    
87. MANN DL
    Heart Failure 2021: A Compendium of Translational Success.
    Circ Res. 2021;128:1419-1420.
    PubMed    
    
    
    
88. BURKHOFF D, Topkara VK, Sayer G, Uriel N, et al
    Reverse Remodeling With Left Ventricular Assist Devices.
    Circ Res. 2021;128:1594-1612.
    PubMed     Abstract available
    
    
    April 2021
89. BLASER MC, Kraler S, Luscher TF, Aikawa E, et al
    Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis.
    Circ Res. 2021;128:1371-1397.
    PubMed     Abstract available
    
    
    
90. TONG D, Schiattarella GG, Jiang N, Altamirano F, et al
    NAD(+) Repletion Reverses Heart Failure with Preserved Ejection Fraction.
    Circ Res. 2021 Apr 22. doi: 10.1161/CIRCRESAHA.120.317046.
    PubMed     Abstract available
    
    
    
91. BOUTOUYRIE P, Chowienczyk P, Humphrey JD, Mitchell GF, et al
    Arterial Stiffness and Cardiovascular Risk in Hypertension.
    Circ Res. 2021;128:864-886.
    PubMed     Abstract available
    
    
    February 2021
92. CHEN K, Wang S, Sun QW, Zhang B, et al
    Klotho Deficiency Causes Heart Aging via Impairing the Nrf2-GR Pathway.
    Circ Res. 2021;128:492-507.
    PubMed     Abstract available
    
    
    
93. MUSTROPH J, Sag CM, Bahr F, Schmidtmann AL, et al
    Loss of CASK Accelerates Heart Failure Development.
    Circ Res. 2021 Feb 17. doi: 10.1161/CIRCRESAHA.120.318170.
    PubMed     Abstract available
    
    
    
94. TAEGTMEYER H
    Heart Failure in Diabetes: Still a Vexing Problem.
    Circ Res. 2021;128:358-359.
    PubMed    
    
    
    
95. MANGNER N, Garbade J, Heyne E, van den Berg M, et al
    Molecular Mechanisms of Diaphragm Myopathy in Humans with Severe Heart Failure.
    Circ Res. 2021 Feb 1. doi: 10.1161/CIRCRESAHA.120.318060.
    PubMed     Abstract available
    
    
    
96. LIU T, Yang N, Sidor A, O'Rourke B, et al
    MCU Overexpression Rescues Inotropy and Reverses Heart Failure by Reducing SR Ca(2+) Leak.
    Circ Res. 2021 Feb 1. doi: 10.1161/CIRCRESAHA.120.318562.
    PubMed     Abstract available
    
    
    January 2021
97. EVANS MA, Walsh K
    A Single-Cell Analysis of DNMT3A-Mediated Clonal Hematopoiesis in Heart Failure.
    Circ Res. 2021;128:229-231.
    PubMed    
    
    
    
98. DENG Y, Xie M, Li Q, Xu X, et al
    Targeting Mitochondria-Inflammation Circuit by beta-Hydroxybutyrate Mitigates HFpEF.
    Circ Res. 2021;128:232-245.
    PubMed     Abstract available
    
    
    
99. PERESTRELO AR, Silva AC, Oliver-De La Cruz J, Martino F, et al
    Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart.
    Circ Res. 2021;128:24-38.
    PubMed     Abstract available
    
    
    
100. PAPA A, Kushner J, Hennessey JA, Katchman AN, et al
     Adrenergic CaV1.2 Activation via Rad Phosphorylation Converges at alpha1C I-II Loop.
     Circ Res. 2021;128:76-88.
     PubMed     Abstract available
     
     
     December 2020
101. WITTENBECHER C, Eichelmann F, Toledo E, Guasch-Ferre M, et al
     Lipid Profiles and Heart Failure Risk: Results from Two Prospective Studies.
     Circ Res. 2020 Dec 4. doi: 10.1161/CIRCRESAHA.120.317883.
     PubMed     Abstract available
     
     
     November 2020
102. ABPLANALP WT, Cremer S, John D, Hoffmann J, et al
     Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure.
     Circ Res. 2020 Nov 6. doi: 10.1161/CIRCRESAHA.120.317104.
     PubMed     Abstract available
     
     
     July 2020
103. SHOEMAKER MB, Roden DM
     Atrial Fibrillation Is a Complex Trait: Very Complex.
     Circ Res. 2020;127:244-246.
     PubMed    
     
     
     May 2020
104. MARTINS-MARQUES T, Catarino S, Goncalves A, Miranda-Silva D, et al
     EHD1 Modulates Cx43 Gap Junction Remodeling Associated With Cardiac Diseases.
     Circ Res. 2020;126:e97-e113.
     PubMed     Abstract available
     
     
     March 2020
105. JOLY JM, Tallaj JA
     The Heart of the (Gray) Matter Is not Black and White.
     Circ Res. 2020;126:765-766.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.